Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

I'm a 79-year-old female.

CHICAGO, IL—Patients with asymptomatic severe aortic stenosis who are watched until symptoms develop before undergoing TAVI are a greater risk of dying, being hospitalized for heart failure (HF), or ...

Please provide your email address to receive an email when new articles are posted on . A transcatheter mitral valve replacement system was approved for patients at high surgical risk. The system is ...

According to the American Heart Association, valvular heart disease affects about 2.5% of adults in the United States, and more than 100,000 patients undergo valve replacement surgery each year.

Overview The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing ...

A team at Duke Health was able to perform the world’s first living mitral valve replacement (Photo: Duke Health) DURHAM, NC (WWAY) — A team at Duke Health was able to perform the world’s first living ...

Even women who felt well before pregnancy may begin to notice symptoms around 28 to 30 weeks, when the cardiovascular system reaches its peak workload.